1 We enrolled 1,764 subjects, including clinically diagnosed PT
2 From 2015 to 2017,
we enrolled 1-to-1 matched intussusception cases and hospital
3 Between Nov 1, 2017, and Aug 3, 2018,
we enrolled 118 patients, of whom 59 were randomly assigned t
4 Between July 15, 2016, and July 20, 2018,
we enrolled 1213 patients.
5 We enrolled 1242 of 1397 adults (89%) living in 533 household
6 Between May 26, 2015, and Feb 14, 2019,
we enrolled 144 patients into part B and 42 patients into par
7 We enrolled 156 patients with a mean age of 56 years; 78 pati
8 From 2014 to 2018,
we enrolled 179 pregnant women into 4 groups: "HLHS/TGA" fetu
9 We enrolled 196 participants; 69.9% were male and 70.4% were
10 We enrolled 20 899 outpatients, of whom 2116 (10.1%) had posi
11 Two years later, in phase 2,
we enrolled 222 new participants, performing serum creatinine
12 We enrolled 243 patients; 141 (58%) were men, and 102 (42%) w
13 Between April 6 and May 9, 2020,
we enrolled 2766 participants from 1339 households, with a de
14 Between Sept 17, 2015, and May 11, 2017,
we enrolled 30 participants (six per panel).
15 We enrolled 30,529 participants between 25 March and 7 June 2
16 We enrolled 31 841 households (53 926 children) in Bangladesh
17 Between April 15, 2014, and Oct 1, 2017,
we enrolled 323 women, of whom 234 had perinatal HIV infectio
18 We enrolled 351 pregnant women and 109 controls with epilepsy
19 Between Nov 3, 2015, and Dec 29, 2018,
we enrolled 478 patients and 462 unique patients were include
20 We enrolled 612 eyes of 391 subjects with progressive keratoc
21 We enrolled 75 CHR individuals with attenuated positive sympt
22 We enrolled 8,705 blood culture confirmed enteric fever cases
23 We enrolled 821 asymptomatic participants.
24 We enrolled 93 PHIV and 99 HIV-uninfected females.
25 We enrolled a prospective cohort of patients with new pulmona
26 In this multi-arm, multicentre, open-label, phase 1b study,
we enrolled adult patients (aged >=18 years) with locally adv
27 We enrolled adult patients (aged >=18 years) with relapsed or
28 ouble-blind, randomised, placebo-controlled, phase 3 study,
we enrolled adult patients in 29 specialised hospitals in 12
29 We enrolled adults who had household or occupational exposure
30 onducted a prospective cohort study in Lima, Peru, in which
we enrolled and followed 14 044 household contacts of adults
31 Between Feb 15 and Sept 10, 2017,
we enrolled and randomly assigned 49 healthy adult participan
32 In five intensive care units (ICUs),
we enrolled conscious, critically ill adults who had a trache
33 We enrolled consecutive patients with paroxysmal or persisten
34 We enrolled double-blind, randomised controlled trials (RCTs)
35 In this prospective population-based cohort study,
we enrolled healthy children residing in Bogo or Balamban, Ce
36 We enrolled healthy newborns and children with metabolic dise
37 Between September 2018 and March 2019,
we enrolled men who have sex with men with nucleic acid ampli
38 We enrolled paediatric or adult patients in two ongoing, mult
39 We enrolled patients (aged 3-64 years) presenting to two Kath
40 We enrolled patients admitted to hospital with suspected or c
41 this multicenter, prospective, observational cohort study,
we enrolled patients aged 6 months to 18 years with newly pla
42 We enrolled patients between Oct 27, 2010, and Feb 13, 2013,
43 We enrolled patients who underwent kidney transplantation and
44 We enrolled patients with a controlled primary malignancy and
45 d study done in 48 acute care hospitals in eight countries,
we enrolled patients with acute ischaemic stroke due to large
46 We enrolled patients with atherosclerotic cardiovascular dise
47 We enrolled patients with locally advanced and/or metastatic
48 We enrolled patients with metastatic RCC with no prior checkp
49 In this double-blind, placebo-controlled, phase 2 trial,
we enrolled patients with or without heterozygous familial hy
50 Last,
we enrolled patients with stage D HF and sampled their blood